Rubina M. Khair

Rubina M. Khair

Pulmonary Medicine | Intensive Care Medicine

3289 Woodburn Rd
350
Annandale, VA 22003

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements.

Right ventricular function as assessed by cardiac magnetic resonance imaging-derived strain parameters compared to high-fidelity micromanometer catheter measurements.

Journal: Pulmonary circulation

Published: April 07, 2021

Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension.

Serum uric acid as a marker of disease risk, severity, and survival in systemic sclerosis-related pulmonary arterial hypertension.

Journal: Pulmonary circulation

Published: March 08, 2019

Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension.

Ventricular mass as a prognostic imaging biomarker in incident pulmonary arterial hypertension.

Journal: The European respiratory journal

Published: August 23, 2018

Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: May 02, 2018

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study.

The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study.

Journal: Pulmonary circulation

Published: December 19, 2017

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: June 30, 2017

The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension.

The Minimal Important Difference in Borg Dyspnea Score in Pulmonary Arterial Hypertension.

Journal: Annals of the American Thoracic Society

Published: March 15, 2016

Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.

Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension.

Journal: Annals of the American Thoracic Society

Published: October 23, 2015

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.

Journal: American journal of respiratory and critical care medicine

Published: September 12, 2015

Vascular receptor autoantibodies in pulmonary arterial hypertension.

Vascular receptor autoantibodies in pulmonary arterial hypertension.

Journal: American journal of respiratory and critical care medicine

Published: February 28, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026